Building on a legacy of innovation that spans more than half a century, Los Angeles
Biomedical Research Institute (LA BioMed) at Harbor-UCLA Medical Center is one of
the country's leading nonprofit biomedical research institutes.
LA BioMed is committed to finding practical, inexpensive solutions to real-world health
problems. Our organization has been serving the citizens of Los Angeles for over 60
years with pioneering and innovative research that led to countless diagnostics, devices
and therapies.
It is often said that “someday they will find a way.” When it comes
to discovery science that drives medical breakthroughs, “they” are
here at LA BioMed and “someday” is today.
Our ability to impact and improve global health through local discoveries
is only proportional to the generosity of others. We thank you for support
and we ask that you continue to help us make ‘someday’ happen today.


About Us

LA BioMed is a non-profit scientific research organization dedicated to saving lives not only in the greater Los Angeles metro area but throughout the world. The organization is located on the Harbor-UCLA Medical Center Campus and affiliated with the David Geffen School of Medicine at UCLA.
Read More

Mission Moment

While no one can be certain of what tomorrow brings, most of us have dreams and plans for the future – especially for our children. That was certainly true for me with my daughter...
Read More


Make a gift through PayPal to the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center by clicking on the Donate button below...

Studies Suggest Coronary Calcium Scores Can Assess Long-Term Risk for Heart Disease

Despite being available for decades, CT-based coronary artery calcium scoring has been subject to debate among doctors on whether, and how, it should be used to inform patient care. Utilizing data from five separate studies, researchers have concluded that coronary artery calcium...

LA BioMed Launches Study of MDMA-Assisted Therapy For Social Anxiety in Autistic Adults MAPS-initiated Research Seeks to Enhance Functional Skills

Seeking new therapies for the treatment of social anxiety in autistic adults, researchers at the Los Angeles Biomedical Research Institute (LA BioMed) announced today that they are initiating a novel study into the safety and effectiveness of MDMA-assisted therapy. The study is...

Emmaus Life Sciences Announces Positive Top-Line Results Of Its Phase 3 Clinical Trial For Sickle Cell Disease

Emmaus Life Sciences, Inc. (the “Company,” or “Emmaus”), a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases, today announced that...

Children Exposed to Methamphetamine before Birth Have Increased Cognitive Problems – Long-term Study Highlights the Need for Early Intervention

In the only long-term, National Institutes of Health-funded study of prenatal methamphetamine exposure and child outcome, researchers found youngsters exposed to the potent illegal drug before birth had increased cognitive problems at age 7.5 years, highlighting the need for...

Join the mailing list

Check your email and confirm the subscription